A new experimental drug is showing remarkable promise for children with Dravet syndrome, a severe genetic form of epilepsy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results